| Revenue | DKK 0 | — |
| EBITDA | DKK -8K | +0% |
| Net profit | DKK 175K | +2% |
| Total assets | DKK 7,9M | +2% |
| Equity | DKK 7,8M | +2% |
| Employees | — | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | -7 | -5 | -6 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -7 | -5 | -6 | -6 | -7 | -7 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -7 | -5 | -6 | -6 | -7 | -7 |
| Net financials | 0 | 213 | 218 | 222 | 227 | 232 |
| Profit before tax | -7 | 208 | 211 | 216 | 220 | 225 |
| Tax | -0 | 44 | 47 | 48 | 49 | 50 |
| Net profit | -7 | 164 | 165 | 168 | 171 | 175 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Total assets | 7.000 | 7.206 | 7.384 | 7.553 | 7.715 | 7.892 |
| Equity | 6.993 | 7.156 | 7.321 | 7.489 | 7.660 | 7.835 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 | 50 | 63 | 64 | 56 | 57 |
| Total debt | 8 | 50 | 63 | 64 | 56 | 57 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FS Management | Management | 2017 | — | — |
MA Unofficial title | Unofficial title | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15.0% | 15.0% | 2017 | |
BIOLID GROUP ApS | Company | 25.0% | 25.0% | 2017 |
| Individual | 10.0% | 10.0% | 2017 | |
| Individual | 20.0% | 20.0% | 2017 | |
| Individual | 20.0% | 20.0% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Finn Søndergaard | Management | 0 companies |
| Michael Anker Transø Falkenberg Schultz | Unofficial title | 0 companies |